AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34802087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram developed based on multivariable logistic regression analysis using predictors such as glucocorticoid injection history, knee OA in the contralateral side, extensor muscle strength, area of cartilage deficiency, bone marrow lesion, and meniscus extrusion.
Number of subjects: 839
Study 33574013 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-headed capsule endoscopy (DH CE)
Number of subjects: 204
Study 33574013 — intervention group
Group type: COMPARATOR
Intervention: Single-headed capsule endoscopy (SH CE)
Number of subjects: 204
Study 34636838 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged release tapentadol
Number of subjects: 30
Study 34636838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34309491 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonate treatment (pamidronate, alendronate, ibandronate)
Number of subjects: 10
Study 34309491 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonate treatment
Number of subjects: 10
Study 35924008 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA (13–15 mg/kg/day) + fenofibrate (200 mg/day)
Number of subjects: 48
Study 35924008 — intervention group
Group type: COMPARATOR
Intervention: UDCA (13–15 mg/kg/day)
Number of subjects: 48
Study 34087055 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin whitening serum containing niacinamide, hydroxyphenoxy propionic acid, dipotassium glycyrrhizate, glycolic acid, and 4‐n‐butylresorcinol applied twice daily combined with a spot‐preventing SPF50+ sunscreen
Number of subjects: 12
Study 34087055 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin whitening serum
Number of subjects: 12
Study 34781972 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and perioperative gabapentin (ITM+GABA group)
Number of subjects: 50
Study 34781972 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine only (ITM group)
Number of subjects: 50
Study 33338644 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists (VKA)
Number of subjects: 17465
Study 33338644 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention reported
Number of subjects: 17465
Study 32037134 — intervention group
Group type: EXPERIMENTAL
Intervention: internet‐based cognitive‐behavioural writing therapy (iCBT) for PTSD
Number of subjects: 2
Study 33632478 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 978
Study 33632478 — intervention group
Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 978
Study 32372689 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 131
Study 32372689 — intervention group
Group type: EXPERIMENTAL
Intervention: Never treated with lithium
Number of subjects: 131
Study 32372689 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 131
Study 35722557 — intervention group
Group type: EXPERIMENTAL
Intervention: Two different therapeutic interventions (specifics not provided)
Number of subjects: 0
Study 34508547 — intervention group
Group type: EXPERIMENTAL
Intervention: DMARD tapering arms
Number of subjects: 108
Study 34508547 — intervention group
Group type: COMPARATOR
Intervention: Continuation of DMARDs
Number of subjects: 108
Study 34508547 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IgA and IgG ACPA
Number of subjects: 108
Study 34508547 — intervention group
Group type: EXPERIMENTAL
Intervention: IgA2 ACPA levels
Number of subjects: 108
Study 35622221 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study 35622221 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study 34009911 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter training intervals (1 or 7 days)
Number of subjects: 0
Study 34009911 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer training intervals (30 or 90 days)
Number of subjects: 0
Study 34009911 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month interval refreshers
Number of subjects: 0
Study 34009911 — intervention group
Group type: EXPERIMENTAL
Intervention: PPO (personalized interval refreshers)
Number of subjects: 0
Study 34009911 — intervention group
Group type: COMPARATOR
Intervention: 6-month interval refreshers
Number of subjects: 0
Study 33978160 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty fish (herring/mackerel)
Number of subjects: 232
Study 32736578 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Treatment (BMT) - four 45-min sessions provided by a general psychologist with at least 3 years of primary care experience.
Number of subjects: 182
Study 32736578 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 182
Study 32736578 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Treatment (BMT)
Number of subjects: 182
Study 36069870 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop therapy
Number of subjects: 97
Study 36069870 — intervention group
Group type: COMPARATOR
Intervention: Control therapy
Number of subjects: 97
Study 33711081 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus deep brain stimulation (STN‐DBS)
Number of subjects: 0
Study 35490437 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG recording latency
Number of subjects: 364
Study 33959986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy
Number of subjects: 0
Study 33959986 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 33362714 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing intervention during appointments every 4 months with the endocrinologist
Number of subjects: 66
Study 33362714 — intervention group
Group type: COMPARATOR
Intervention: Control group with usual appointments
Number of subjects: 66
Study 35279220 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2-laser irradiation in combination with fluoride therapy
Number of subjects: 0
Study 35279220 — intervention group
Group type: COMPARATOR
Intervention: Fluoride therapy alone
Number of subjects: 0
Study 34381108 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA (3 g/d)
Number of subjects: 21
Study 34381108 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (3 g/d)
Number of subjects: 21
Study 34381108 — intervention group
Group type: COMPARATOR
Intervention: High oleic acid sunflower oil (3 g/day, baseline)
Number of subjects: 21
Study 32899117 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosomes from night shift (NS) condition
Number of subjects: 14
Study 32899117 — intervention group
Group type: COMPARATOR
Intervention: Exosomes from day shift (DS) condition
Number of subjects: 14
Study 34338733 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscrews
Number of subjects: 24
Study 34338733 — intervention group
Group type: COMPARATOR
Intervention: Essix appliance
Number of subjects: 24
Study 32096902 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Mastoid Electrical Stimulator (PMES) daily for 45 minutes for three months
Number of subjects: 90
Study 32096902 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraorbital Transcutaneous Stimulator (STS) daily for 20 minutes for three months
Number of subjects: 90
Study 32096902 — intervention group
Group type: COMPARATOR
Intervention: Supraorbital Transcutaneous Stimulator (STS)
Number of subjects: 90
Study 32096902 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Mastoid Electrical Stimulator (PMES)
Number of subjects: 90
Study 36323056 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital single-session intervention teaching malleability beliefs about personal traits and symptoms (growth mindset)
Number of subjects: 638
Study 34461298 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination intervention (proactive symptom monitoring and care coordinator-triggered algorithms)
Number of subjects: 205
Study 34461298 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study 34158253 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise during NACRT and unsupervised exercise after NACRT
Number of subjects: 36
Study 34158253 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study 32278346 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular glucocorticoid injection (40 mg triamcinolone acetonide)
Number of subjects: 140
Study 32278346 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular glucocorticoid injection (40 mg triamcinolone acetonide)
Number of subjects: 140
Study 35672525 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 5
Study 35672525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 33858221 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-session single-family intervention to improve individual and family functioning
Number of subjects: 61
Study 33858221 — intervention group
Group type: COMPARATOR
Intervention: Control group (rehabilitation at a specialised traumatic brain injury outpatient clinic)
Number of subjects: 61
Study 34637645 — intervention group
Group type: EXPERIMENTAL
Intervention: 2min‐130% ‐ FATmax
Number of subjects: 12
Study 34637645 — intervention group
Group type: EXPERIMENTAL
Intervention: 20s:10s‐170% ‐ FATmax
Number of subjects: 12
Study 34637645 — intervention group
Group type: COMPARATOR
Intervention: FATmax
Number of subjects: 12
Study 34637645 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity bouts
Number of subjects: 12
Study 33843566 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning condition (health warning present)
Number of subjects: 1064
Study 33843566 — intervention group
Group type: COMPARATOR
Intervention: No Warning condition (health warning absent)
Number of subjects: 1064
Study 33874964 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic care for 2 weeks
Number of subjects: 200
Study 33874964 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 200
Study 32503606 — intervention group
Group type: EXPERIMENTAL
Intervention: ActWELL lifestyle intervention programme
Number of subjects: 0
Study 33607979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer driven walking program (WG) for 12 weeks, guided by a physiotherapist
Number of subjects: 174
Study 33607979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer driven walking program (WG) for 12 weeks
Number of subjects: 174
Study 33607979 — intervention group
Group type: COMPARATOR
Intervention: Standardized care group (SG)
Number of subjects: 174
Study 32618245 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass Drug Administration (MDA)
Number of subjects: 2026
Study 32618245 — intervention group
Group type: COMPARATOR
Intervention: focal Mass Drug Administration (fMDA)
Number of subjects: 2026
Study 32618245 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 2026
Study 34762845 — intervention group
Group type: EXPERIMENTAL
Intervention: PROCUIDA-Demencia intervention (2-day staff training program)
Number of subjects: 55
Study 34762845 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 55
Study 33233020 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) intervention, 5-week escalating with reset; adjunct to standard smoking cessation treatment.
Number of subjects: 40
Study 33233020 — intervention group
Group type: COMPARATOR
Intervention: Standard smoking cessation treatment (control group not explicitly detailed).
Number of subjects: 40
Study 33372185 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 2.5 mg
Number of subjects: 0
Study 33372185 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 0
Study 33372185 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 0
Study 33372185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35170727 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligo/Amen + Cal
Number of subjects: 76
Study 35170727 — intervention group
Group type: COMPARATOR
Intervention: Oligo/Amen Control
Number of subjects: 76
Study 33658261 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention with weekly calls from registered dietitian nutritionists using motivational interviewing
Number of subjects: 0
Study 33658261 — intervention group
Group type: COMPARATOR
Intervention: Self-directed lifestyle intervention
Number of subjects: 0
Study 33658261 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 0
Study 32913018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly
Number of subjects: 1890
Study 32913018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly
Number of subjects: 1890
Study 35361446 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal guideline-directed medical therapy (GDMT) including beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and mineralocorticoid receptor antagonists
Number of subjects: 879
Study 35361446 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal GDMT triple therapy use
Number of subjects: 879
Study 32859257 — intervention group
Group type: EXPERIMENTAL
Intervention: Calamansi drink
Number of subjects: 10
Study 32859257 — intervention group
Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 10
Study 34864480 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial behaviour (donating money to preferred charities)
Number of subjects: 180
Study 34864480 — intervention group
Group type: COMPARATOR
Intervention: Non-prosocial behaviour (neutral number judgement task or proself task)
Number of subjects: 180
Study 32178334 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Appreciation Scale‐2 (BAS‐2‐LT)
Number of subjects: 1412
Study 34284152 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Number of subjects: 60
Study 34284152 — intervention group
Group type: COMPARATOR
Intervention: Take Control (TC)
Number of subjects: 60
Study 33818752 — intervention group
Group type: EXPERIMENTAL
Intervention: Shear wave elastography (SWE)
Number of subjects: 69
Study 33818752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (US)
Number of subjects: 69
Study 33818752 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) curve analysis
Number of subjects: 69
Study 34088228 — intervention group
Group type: EXPERIMENTAL
Intervention: Family old age care
Number of subjects: 1553
Study 34088228 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of family old age care plus community old age care
Number of subjects: 1553
Study 34088228 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related services demands
Number of subjects: 1553
Study 34088228 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital as care service provider
Number of subjects: 1553
Study 34088228 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for long-term care and emergency call
Number of subjects: 1553
Study 35485295 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic liner
Number of subjects: 53
Study 35485295 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene liner
Number of subjects: 53
Study 35485295 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study 34965635 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shock wave therapy with centrifugal exercise
Number of subjects: 53
Study 34965635 — intervention group
Group type: COMPARATOR
Intervention: Centrifugal exercise alone
Number of subjects: 53
Study 34555421 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-visit retreatment
Number of subjects: 40
Study 34555421 — intervention group
Group type: COMPARATOR
Intervention: 2-visit retreatment
Number of subjects: 40
Study 34555421 — intervention group
Group type: COMPARATOR
Intervention: Control (2-visit retreatment)
Number of subjects: 40
Study 32407535 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59‐adjuvanted vaccine (FLUAD; Seqirus)
Number of subjects: 0
Study 32407535 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐dose vaccine (Fluzone High‐Dose; Sanofi Pasteur)
Number of subjects: 0
Study 32407535 — intervention group
Group type: COMPARATOR
Intervention: Standard‐dose inactivated influenza vaccine (FluQuadri; Sanofi Pasteur)
Number of subjects: 0
Study 32407535 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hemagglutinin vaccine (Flublok; Sanofi Pasteur)
Number of subjects: 0
Study 32407535 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccines
Number of subjects: 0
Study 35797065 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery combined with structured progressive circuit class therapy
Number of subjects: 40
Study 35797065 — intervention group
Group type: COMPARATOR
Intervention: Health education combined with structured progressive circuit class therapy
Number of subjects: 40
Study 33910607 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographic assessment of pressure ulcers
Number of subjects: 2029
Study 33910607 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded central review using photographs
Number of subjects: 2029
Study 33910607 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of skin classification
Number of subjects: 2029
Study 32548283 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent image quality MRI
Number of subjects: 990
Study 32548283 — intervention group
Group type: COMPARATOR
Intervention: Non-adherent image quality MRI
Number of subjects: 990
Study 33941192 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (140 mg every two weeks or 420 mg monthly)
Number of subjects: 585
Study 35003321 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban therapy (research group)
Number of subjects: 157
Study 35003321 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulation therapy (standard group)
Number of subjects: 157
Study 36045371 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with hydroxyapatite (HA)
Number of subjects: 154
Study 36045371 — intervention group
Group type: COMPARATOR
Intervention: Auto-iliac bone graft
Number of subjects: 154
Study 33249220 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam-assisted sedation (Group A)
Number of subjects: 106
Study 33249220 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl plus midazolam-assisted sedation (Group B)
Number of subjects: 106
Study 33249220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 106
Study 32634172 — intervention group
Group type: EXPERIMENTAL
Intervention: Crew size of 2
Number of subjects: 140
Study 32634172 — intervention group
Group type: EXPERIMENTAL
Intervention: Crew size of 3
Number of subjects: 140
Study 32634172 — intervention group
Group type: EXPERIMENTAL
Intervention: Crew size of 4
Number of subjects: 140
Study 32634172 — intervention group
Group type: EXPERIMENTAL
Intervention: Crew size of 5
Number of subjects: 140
Study 32634172 — intervention group
Group type: EXPERIMENTAL
Intervention: Crew size of 6
Number of subjects: 140
Study 32634172 — intervention group
Group type: EXPERIMENTAL
Intervention: Troubleshooting of M-CPR machine
Number of subjects: 140
Study 34972714 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourier-transform infrared spectroscopy and mathematical simulation models
Number of subjects: 56
Study 33626041 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex milk lipid-enhanced (CML-E) group - same formulation enriched with complex milk lipids (≥8 mg gangliosides/day)
Number of subjects: 1500
Study 33626041 — intervention group
Group type: COMPARATOR
Intervention: Control - received standard powdered milk formulation (≥4 mg gangliosides/day)
Number of subjects: 1500
Study 33626041 — intervention group
Group type: COMPARATOR
Intervention: Reference - received no milk
Number of subjects: 1500
Study 32037653 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 6969
Study 32037653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6969
Study 34251840 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy + Drug (told active CBD - given active CBD)
Number of subjects: 15
Study 34251840 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug (told inactive - given active CBD)
Number of subjects: 15
Study 34251840 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy (told active CBD - given inactive)
Number of subjects: 15
Study 34251840 — intervention group
Group type: COMPARATOR
Intervention: Control (told inactive - given inactive)
Number of subjects: 15
Study 33826277 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intradialytic exercise program for 16 weeks
Number of subjects: 71
Study 33826277 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program supervised by physical therapists for 16 weeks
Number of subjects: 71
Study 34228956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT)
Number of subjects: 44
Study 34228956 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 44
Study 35770597 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote acupuncture
Number of subjects: 60
Study 35770597 — intervention group
Group type: COMPARATOR
Intervention: Local acupuncture
Number of subjects: 60
Study 35752839 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 81
Study 35752839 — intervention group
Group type: COMPARATOR
Intervention: Conventional lecture
Number of subjects: 81
Study 35752839 — intervention group
Group type: COMPARATOR
Intervention: Before intervention
Number of subjects: 81
Study 35752839 — intervention group
Group type: EXPERIMENTAL
Intervention: After VR training
Number of subjects: 81
Study 32713741 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural American Spirit (NAS) cigarettes
Number of subjects: 1003
Study 32713741 — intervention group
Group type: COMPARATOR
Intervention: Pall Mall cigarettes
Number of subjects: 1003
Study 35763390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU per day
Number of subjects: 635
Study 34605057 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen Matrix (CMX)
Number of subjects: 60